Pearland Brokerage

Conversion Venture Capital (CVC2) is a private equity firm based in New York, NY, that specializes in providing flexible long-term funding solutions to businesses. With a founder-focused philosophy and decades of investment experience, CVC2 aims to unlock lasting value for its partners by fostering authentic connections and aligning success with their clients' visions. CVC2 invests in both established market leaders and emerging companies, offering support through growth capital, co-investments, and control investments. Their commitment to sustainability and responsible investing resonates with their partners, ensuring a shared vision for achieving long-term strategic goals. Generated from the website

Founded in 1991, Behrman Capital is a private equity investment firm with more than $2.0 billion of capital under management. The firm invests in the management buyout, leveraged buildup and recapitalization of established growth companies. Behrman Capital specializes in the health care, defense, specialty manufacturing, business-to-business outsourcing and information technology industries. It partners with various institutions, including The National Geographic Society, BankAmerica, the Bank of Nova Scotia, AXA, Partners Group, Hamilton Lane Fund of Funds, Illinois State Board and Wilshire Associates. Behrman Capital makes investments in Ark Holding Company, Athena Diagnostics, Esoterix, Tandem Health Care, and Wil Research Laboratories.